Show simple item record

dc.contributor.authorKissling, Esther
dc.contributor.authorRose, Angela
dc.contributor.authorEmborg, Hanne-Dorthe
dc.contributor.authorGherasim, Alin Manuel 
dc.contributor.authorPebody, Richard
dc.contributor.authorPozo Sanchez, Francisco 
dc.contributor.authorTrebbien, Ramona
dc.contributor.authorMazagatos, Clara 
dc.contributor.authorWhitaker, Heather
dc.contributor.authorValenciano, Marta
dc.contributor.authorEuropean IVE group
dc.contributor.authorLarrauri, Amparo 
dc.contributor.authorCasas Flecha, Inmaculada 
dc.contributor.authorDelgado-Sanz, Concepcion 
dc.contributor.authorOliva Dominguez, Jesus Angel 
dc.date.accessioned2020-01-29T11:50:04Z
dc.date.available2020-01-29T11:50:04Z
dc.date.issued2019
dc.identifier.citationEuro Surveill. 2019 Feb;24(8):1900121.es_ES
dc.identifier.issn1560-7917es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/8980
dc.description.abstractInfluenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates among all ages in primary care was 32-43% against influenza A; higher against A(H1N1)pdm09 and lower against A(H3N2). Among hospitalised older adults, VE estimates were 34-38% against influenza A and slightly lower against A(H1N1)pdm09. Influenza vaccination is of continued benefit during the ongoing 2018/19 influenza season.es_ES
dc.description.sponsorshipFunding: ECDC has contributed to fund some of the study sites and the coordination of the EU-PC study. WHO-EURO has contributed to fund the Romanian site in EU-PC and EU-H. Epiconcept has contributed to fund the EU-H study.es_ES
dc.language.isoenges_ES
dc.publisherEuropean Centre for Disease Prevention and Control (ECDC) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectEuropees_ES
dc.subjectInfluenzaes_ES
dc.subjectMulticentre studyes_ES
dc.subjectTest-negative designes_ES
dc.subjectVaccinationes_ES
dc.subjectVaccine effectivenesses_ES
dc.subjectVaccines and immunisationes_ES
dc.titleInterim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019es_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID30808440es_ES
dc.format.volume24es_ES
dc.format.number8es_ES
dc.identifier.doi10.2807/1560-7917.ES.2019.24.1900121es_ES
dc.description.peerreviewedSíes_ES
dc.identifier.e-issn1560-7917es_ES
dc.relation.publisherversionhttps://doi.org/10.2807/1560-7917.ES.2019.24.1900121es_ES
dc.identifier.journalEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletines_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES


Files in this item

Acceso Abierto
Thumbnail
Name:
Interim201819InfluenzaVaccine_ ...
Size:
562.7Kb
Format:
PDF
FilesOpen

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This item is licensed under a: Atribución 4.0 Internacional